Wilder-Smith A - Search Results

1

Misguided approach to dengue vaccine risk.

Wilder-Smith A, Hombach J, Cravioto A. Wilder-Smith A, et al. Science. 2019 Nov 29;366(6469):1082-1083. doi: 10.1126/science.aaz6159. Science. 2019. PMID: 31780549 No abstract available.

2

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.

Wilder-Smith A, Hombach J, Ferguson N, Selgelid M, O'Brien K, Vannice K, Barrett A, Ferdinand E, Flasche S, Guzman M, Novaes HM, Ng LC, Smith PG, Tharmaphornpilas P, Yoon IK, Cravioto A, Farrar J, Nolan TM. Wilder-Smith A, et al. Lancet Infect Dis. 2019 Jan;19(1):e31-e38. doi: 10.1016/S1473-3099(18)30494-8. Epub 2018 Sep 5. Lancet Infect Dis. 2019. PMID: 30195995 Review.

3

Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine.

Wilder-Smith A, Vannice KS, Hombach J, Farrar J, Nolan T. Wilder-Smith A, et al. J Infect Dis. 2016 Dec 15;214(12):1796-1799. doi: 10.1093/infdis/jiw341. Epub 2016 Aug 5. J Infect Dis. 2016. PMID: 27496977 No abstract available.

4

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.

Vannice KS, Wilder-Smith A, Barrett ADT, Carrijo K, Cavaleri M, de Silva A, Durbin AP, Endy T, Harris E, Innis BL, Katzelnick LC, Smith PG, Sun W, Thomas SJ, Hombach J. Vannice KS, et al. Vaccine. 2018 Jun 7;36(24):3411-3417. doi: 10.1016/j.vaccine.2018.02.062. Epub 2018 Mar 7. Vaccine. 2018. PMID: 29525283 Free PMC article.

5

Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.

Vannice K, Wilder-Smith A, Hombach J. Vannice K, et al. N Engl J Med. 2018 Aug 16;379(7):603-605. doi: 10.1056/NEJMp1803433. Epub 2018 Jul 11. N Engl J Med. 2018. PMID: 29995585 Free article. No abstract available.

6

Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates.

Vannice KS, Cassetti MC, Eisinger RW, Hombach J, Knezevic I, Marston HD, Wilder-Smith A, Cavaleri M, Krause PR. Vannice KS, et al. Vaccine. 2019 Feb 4;37(6):863-868. doi: 10.1016/j.vaccine.2018.12.040. Epub 2019 Jan 11. Vaccine. 2019. PMID: 30639461 Free PMC article.

7

Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines.

Flasche S, Wilder-Smith A, Hombach J, Smith PG. Flasche S, et al. Wellcome Open Res. 2019 Oct 31;4:165. doi: 10.12688/wellcomeopenres.15507.1. eCollection 2019. Wellcome Open Res. 2019. PMID: 31815190 Free PMC article.

8

Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Staples JE, Barrett ADT, Wilder-Smith A, Hombach J. Staples JE, et al. NPJ Vaccines. 2020 Jul 6;5(1):54. doi: 10.1038/s41541-020-0205-6. eCollection 2020. NPJ Vaccines. 2020. PMID: 32655896 Free PMC article. Review.

9

Caution before fractionating COVID-19 vaccines.

Wilder-Smith A, Desai S, Cravioto A, Nohynek H, Hombach J. Wilder-Smith A, et al. Nat Med. 2021 Nov;27(11):1856-1857. doi: 10.1038/s41591-021-01534-z. Nat Med. 2021. PMID: 34552264 No abstract available.

10

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.

Parker EPK, Desai S, Marti M, Nohynek H, Kaslow DC, Kochhar S, O'Brien KL, Hombach J, Wilder-Smith A. Parker EPK, et al. Lancet Glob Health. 2022 Mar;10(3):e326-e328. doi: 10.1016/S2214-109X(21)00593-3. Lancet Glob Health. 2022. PMID: 35180408 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page